company background image
4188 logo

AmCad BioMed TPEX:4188 Stock Report

Last Price

NT$18.60

Market Cap

NT$1.2b

7D

-7.7%

1Y

-33.6%

Updated

14 Mar, 2025

Data

Company Financials

AmCad BioMed Corporation

TPEX:4188 Stock Report

Market Cap: NT$1.2b

4188 Stock Overview

Develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan. More details

4188 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

AmCad BioMed Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for AmCad BioMed
Historical stock prices
Current Share PriceNT$18.60
52 Week HighNT$31.00
52 Week LowNT$18.75
Beta0.89
1 Month Change-11.22%
3 Month Change-14.29%
1 Year Change-33.57%
3 Year Change2.76%
5 Year Change47.62%
Change since IPO-70.48%

Recent News & Updates

Recent updates

Companies Like AmCad BioMed (GTSM:4188) Are In A Position To Invest In Growth

Apr 19
Companies Like AmCad BioMed (GTSM:4188) Are In A Position To Invest In Growth

AmCad BioMed (GTSM:4188) Is In A Good Position To Deliver On Growth Plans

Jan 04
AmCad BioMed (GTSM:4188) Is In A Good Position To Deliver On Growth Plans

Shareholder Returns

4188TW Medical EquipmentTW Market
7D-7.7%-0.7%-3.4%
1Y-33.6%-8.5%9.1%

Return vs Industry: 4188 underperformed the TW Medical Equipment industry which returned -8.5% over the past year.

Return vs Market: 4188 underperformed the TW Market which returned 9.1% over the past year.

Price Volatility

Is 4188's price volatile compared to industry and market?
4188 volatility
4188 Average Weekly Movement2.6%
Medical Equipment Industry Average Movement4.2%
Market Average Movement4.4%
10% most volatile stocks in TW Market7.8%
10% least volatile stocks in TW Market2.1%

Stable Share Price: 4188 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 4188's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2008n/aYi-Li Leewww.amcad.com.tw

AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan. It offers products for early detection and diagnosis of various diseases, such as thyroid cancers, fatty liver, liver fibrosis, and obstructive sleep apnea. The company’s products include AmCAD-UT Detection, a CAD device for ultrasound images of thyroid nodules; and AmCAD-UO for detection of obstructive sleep apnea on awake patients.

AmCad BioMed Corporation Fundamentals Summary

How do AmCad BioMed's earnings and revenue compare to its market cap?
4188 fundamental statistics
Market capNT$1.20b
Earnings (TTM)-NT$50.58m
Revenue (TTM)NT$53.11m

22.2x

P/S Ratio

-23.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4188 income statement (TTM)
RevenueNT$53.11m
Cost of RevenueNT$20.17m
Gross ProfitNT$32.93m
Other ExpensesNT$83.51m
Earnings-NT$50.58m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.80
Gross Margin62.02%
Net Profit Margin-95.24%
Debt/Equity Ratio0%

How did 4188 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/14 14:58
End of Day Share Price 2025/03/14 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

AmCad BioMed Corporation is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pinghan HsiehCapital Securities Corporation